🔎 Trials Near Me

Home › Myelofibrosis › Missouri › St. Louis

Myelofibrosis clinical trials in St. Louis, MO

8 studies for Myelofibrosis are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

RecruitingPhase 1/2
  • Washington University St.Louis, St Louis
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT05320198

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

RecruitingPhase 1/2
  • Washington University of Medicine, St Louis
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

RecruitingPhase 3
  • Washington University School of Medicine, St Louis
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07623161

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Washington University School of Medicine, St Louis
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694

Therapeutic RSK1 Targeting in Myelofibrosis

RecruitingPhase 1
  • Washington University School of Medicine, St Louis
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT07379125

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Washington University School of Medicine, St Louis
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, St Louis
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Myelofibrosis trials in other cities

Other studies in St. Louis

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.